Latest in Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
Sort by
387 items
-
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street's concerns with its fourth-quarter results and 2025 outlook.CNBC - 1h -
Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.The New York Times - 2h -
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.CNBC - 4h -
Ozempic-Like Drug Failed to Treat Parkinson’s Disease in Trial
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other conditions with newer weight-loss drugs.The New York Times - 21h -
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.The Wall Street Journal - Jan. 24 -
Novo Nordisk sales beat estimates, but the story wasn’t Ozempic
Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs.MarketWatch - 12h -
Will This New GLP-1 Drug be More Powerful Than Ozempic?
Investors seek answers on Novo Nordisk’s next-gen obesity drug, CagriSema.Inc. - 1d -
Novo Nordisk Foundation Will Not Fill Funding Gaps
Global health experts have questioned how philanthropies could mitigate Trump’s freeze on foreign health aid.Inc. - 2d -
ASML shares jump 10% as surge in orders defies fears of DeepSeek hitting AI chip demand
Dutch semiconductor equipment maker ASML on Wednesday reported better-than-expected net sales and profit results for the fourth quarter.CNBC - Jan. 29 -
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.CNBC - Jan. 28 -
Novo Nordisk shares pop on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.CNBC - Jan. 24 -
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.The Wall Street Journal - Jan. 24 -
NFL playoff ticket sales: Bills vs. Chiefs in record demand, Eagles vs. Commanders outselling past NFC finale
StubHub reveals some eye-popping numbers for Sunday's conference championshipsCBS Sports - Jan. 24 -
Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.
Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.MarketWatch - Jan. 24 -
Burberry shares jump 13% after better-than-expected quarterly sales
Burberry on Friday reported a shallower-than-expected dip in sales in the fiscal third quarter, in the first glimpse of fresh efforts to revamp the beleaguered British fashion house.CNBC - Jan. 24 -
Adidas Exceeds Profit Guidance After Sales Jump in Fourth Quarter
The German sporting-goods company said its operating profit climbed to €1.34 billion last year from €268 million in 2023.The Wall Street Journal - Jan. 21 -
Ozempic picked for Medicare price bargaining
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden adds Ozempic to list for Medicare price negotiation In one of its last actions, the Biden administration ...The Hill - Jan. 17 -
Obesity drugs Ozempic and Wegovy included in US price-cut talks
Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiationsFinancial Times - Jan. 17 -
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.The Wall Street Journal - Jan. 17 -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - Jan. 17 -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - Jan. 17 -
CMS to seek Medicare negotiations on Ozempic price
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...The Hill - Jan. 17 -
Shares of Cartier owner Richemont jump 16% as sales rise in December quarter
Cartier owner Richemont on Thursday reported a 10% increase in third quarter sales even as China demand weighed.CNBC - Jan. 16 -
26th Annual IGF Awards Nominees Announced
The 26th annual Independent Games Festival Awards (IGF for short) has announced the categories and nominees for the upcoming show. The ceremony will be livestreamed on March 19 at 6:30 PM PT / 9:30 ...GameSpot - Jan. 16 -
Lululemon’s stock jumps as strong holiday sales show demand is improving
Lululemon’s stock rallies toward a 10-month high after guidance for profit, revenue and gross margin were raised.MarketWatch - Jan. 13 -
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?Wired - Jan. 13 -
Pope Francis baptizes 21 babies in annual ceremony at the Sistine Chapel
Pope Francis has baptised 21 babies in the Sistine Chapel on Sunday under the ceiling frescoed by Michelangelo, in what has become an annual tradition that marks the end of the Christmas holiday ...ABC News - Jan. 12 -
Baby boomers and ‘Ozempic face’ drive injectables craze
People ‘want to look what they feel like, not what they may look like’ says dermatology giant GaldermaFinancial Times - Jan. 12 -
28th Annual DICE Awards Nominees Revealed
The 28th annual DICE Awards has revealed the categories and nominees for this year's show. The show will be livestreamed on February 13 at 8 PM PT / 11 PM ET.. For the coveted Game of the Year ...GameSpot - Jan. 10 -
Emma Raducanu bitten by jumping ants
Emma Raducanu has become the latest victim of Australia’s famously hostile wildlife – although it was not spiders or snakes in her case, but rather “jumping ants”.Yahoo Sports - Jan. 10 -
How Trump’s Greenland Plan Could Hit Ozempic, Legos and Hearing Aids
Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular medicines.The New York Times - Jan. 9 -
Costco’s holiday-season sales jump was not just about food, analyst says
Costco Wholesale Corp. on Wednesday reported a 9.9% year-over-year sales gain through the final stretch of the holiday-shopping season, marked by a big jump in online sales.MarketWatch - Jan. 8 -
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...MarketWatch - Jan. 8 -
Annual ‘winners’ for most egregious US healthcare profiteering announced
Selling body parts without consent and billing desperate parents $97,599 for air transport among worst examples. The 2024 “winners” of the annual Shkreli awards , given each year to perpetrators ...The Guardian - Jan. 7
